Prestige Consumer Healthcare Inc.

NYSE:PBH

Medical - Distribution

Healthcare
$50.62 +0.49%

+$0.23 today

Market cap
$2.40B
Beta
0.35
P/E (TTM)
11.6
EPS (TTM)
$4.01
52W Low $42.62High $85.29

Volume 0.62M

Average 0.67M

PBH Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Prestige Consumer Healthcare Inc.NYSE: PBH

Income Tax Expense · Q1 FY2027 · quarter ended Jun 2026

Income tax expense declines year over year

Q1 FY2027 income tax expense of $9.36M fell 34.6% year over year, behind the -16.5% change in trailing-twelve-month income tax expense. Sequentially, it fell 13.6% from the prior quarter.

Context

  • Income tax expense amounted to 6.2% of revenue in FY2026, unchanged from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -34.6% toward the trailing-twelve-month pace of -16.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$9.36M-13.6% QoQ
Last fiscal yearMar 2026
$67.2M-3.4% YoY
LTMJun 2026
$62.25M-16.5% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-34.6%——
1 year-3.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2026
67.2M USD
Year-over-year change
-3.4%
4-year CAGR
+4.2%

Income Tax Expense vs competitors

How PBH compares with its peers on the latest reported figures

  • PBH's LTM Jun 2026 income tax expense of $62.25M is the 3rd highest of the 11 companies compared; the peer median is $193K.
  • Its year-over-year change of -16.5% is the 6th highest of 10, against a peer median of +23.0%.
  • Income tax expense amounts to 5.6% of revenue for PBH, versus a peer median of 1.4%.
PBH Competitors Peer median
Income Tax Expense for PBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$75.14M +23.0%+47.3%12.6%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$68.23M +25.8%-1.1%2.9%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$62.25M -16.5%—5.6%
LEGNLegend Biotech CorporationLTM Sep 2026$32.42M +88.3%+183.2%2.4%
PRVAPrivia Health Group, Inc.LTM Jun 2026$22.27M +98.6%—0.9%
IRONDisc Medicine, Inc.LTM Sep 2026$317K -29.4%——
ATECAlphatec Holdings, Inc.LTM Mar 2026$69K +25.5%—0.0%
HTFLHeartflow, Inc. Common StockLTM Sep 2026-$97K -203.2%—0.0%
ZLABZai Lab LimitedLTM Jun 2026-$2.51M ——0.6%
ICUIICU Medical, Inc.LTM Jun 2026-$30.96M -158.6%—1.4%
LIVNLivaNova PLCLTM Sep 2026-$76.67M -400.5%+25.0%5.1%
Peer median (excluding PBH) $193K+23.0%+36.2%1.4%

Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.09B1.13B1.13B1.14B1.09B
Cost of Revenue466.17M502.43M500.91M503.3M514.07M
Gross Profit620.65M625.29M624.45M634.46M574.64M
Gross Margin57.1%55.4%55.5%55.8%52.8%
Research & Development00000
Selling, General & Admin264.8M252.42M259.47M263.93M265.23M
Operating Expenses290.73M647.71M282.02M297.69M265.23M
Depreciation & Amortization32.09M32.63M30.68M30.17M31.27M
EBITDA358.84M7.87M373.86M361.99M331.11M
EBITDA Margin33.0%0.7%33.2%31.8%30.4%
Operating Income329.92M(22.42M)342.43M336.78M309.41M
Operating Margin30.4%-2.0%30.4%29.6%28.4%
Interest Income00000
Interest Expense64.29M69.16M67.16M47.63M42.34M
Other Income / Expenses(67.46M)(71.5M)(66.4M)(52.59M)(51.91M)
Income Before Tax262.46M(93.92M)276.03M284.19M257.5M
Pre-Tax Margin24.1%-8.3%24.5%25.0%23.7%
Income Tax Expense57.08M(11.61M)66.69M69.58M67.2M
Net Income205.38M(82.31M)209.34M214.61M190.3M
Net Margin18.9%-7.3%18.6%18.9%17.5%
EPS (Basic)4.09(1.65)4.214.323.93
EPS (Diluted)4.04(1.65)4.174.293.91
Weighted Avg Shares50.26M49.88M49.76M49.7M48.46M
Weighted Avg Shares (Diluted)50.84M49.89M50.18M50.08M48.72M

Prestige Consumer Healthcare Inc.

NYSE:PBH

Intrinsic Alpha fair value

Locked

Current Price

$50.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.